Research demonstrates formic acid decreases seeding activity of alpha-synuclein in human and mouse brains, highlighting safety improvements for histopathological analysis.
Abstract α-Synuclein (α-syn) is an abundant monomeric protein that can aggregate into fibrils and form neuropathological inclusions in the brains of patients with synucleinopathies. New evidence suggests that the mouse-human transmission barrier of α-syn is lower than previously reported, emphasizing the need for improved biosafety procedures when working with α-syn aggregates. Histopathology of α-syn-infected brain represents a significant potential source of occupational exposure, and current methods for tissue fixation do not inactivate the ability of pathologic α-syn to seed the conversion of endogenous, monomeric α-syn into fibrils. In this study, we tested whether 96% formic acid treatment could reduce the seeding activity of α-syn aggregates in paraformaldehyde-fixed brain samples from dementia with Lewy bodies (DLB) patients and α-syn pre-formed fibrils (PFF)-injected mouse brains. Using real-time quaking-induced conversion (RT-QuIC), we found that formic acid treatment reduced α-syn seeding dose (picograms of α-syn seeds per ml of brain homogenate) in DLB and mouse brain by 6 and 8 logarithms, respectively. RT-QuIC reactions seeded with formic acid-treated brain homogenates showed significantly longer lag phase, and decreased total thioflavin T fluorescence compared to untreated samples, indicating that formic acid treatment impairs the ability of pathological α-syn to seed monomeric α-syn. Importantly, the α-syn pathologic features and the immunostaining quality were preserved in formic acid-treated tissues. Our results demonstrate that formic acid treatment is a quick and efficient procedure for reducing α-syn seeding activity in fixed brain samples, thereby lowering the risk of accidental exposure in laboratories without compromising the quality of histopathological analysis. Summary Formic acid treatment drastically reduces α -synuclein seeding activity in fixed human and mouse brain samples while preserving histopathological quality.
No takes yet. Share an insight, caveat, or question.
Digraskar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: